| Industry
Industry name |
Pharmaceuticals |
| Variance
Full Year Net Profit Variance |
15 |
| Equity
Latest Equity |
24.55 |
| Face Value
Latest Face Value |
2 |
| Reserves
Total Reserve |
3307.59 |
| Dividend
Full Year Dividend % |
250 |
| Sales Turnover
Full Year Net Sales |
2551.83 |
| Net Profit
Full Year Net Profit |
549.68 |
| Full Year CPS
Full Year Cash Per Share |
50.9 |
| Earning Per Share
Full Year Earning Per Share |
44.8 |
| Quarter CPS
Latest quarter Cash Per Share |
0 |
| Latest Quarter Date
Latest Quarter Yrc |
Jun 1, 2026 |
| Latest Quarter Sales
Latest Quarter Net Sales |
640.41 |
| Previous EPS
Previous earnings per share |
0 |
| Book Value
Book value |
271.4 |
| Networth
Full Year Return on Networth |
18.36 |
| Price/Book Value
Price to Book value |
5.132646 |
| Yearly PE ratio
Full Year Price to Earning per share |
31.1 |
| Yearly PC ratio
Full Year Price to Cash Per Share |
27.4 |
| Bse value
BSE Value in lakhs |
60.97 |
| Nse value
NSE Value in lakhs |
2167.7 |
| High
52 week high |
1416 |
| Low
52 week low |
830 |
| Price
NSE Current market price |
1394 |
| CPM
Current market price |
1393 |
| Market cap
BSE / NSE Market Cap |
17106.97 |
| Net profit
Latest Quarter Net Profit |
160.08 |
| Net profit variance
Latest Quarter Net Profit variance |
32 |
| Result year
Trailing latest month |
Jun 1, 2026 |
| TTM Sales
Trailing Twelve 12 month Net Sales |
2204.9 |
| TTM OP
Trailing Twelve 12 month Operating Profit |
633.5 |
| TTM OPM
Trailing Twelve 12 month Operating Profit Margin |
28.73 |
| TTM GP
Trailing Twelve 12 month Gross Profit |
879.43 |
| TTM GPM
Trailing Twelve 12 month Gross Profit Margin |
33.95 |
| TTM NP
Trailing Twelve 12 month Net Profit |
423.5 |
| TTM NPV
Trailing Twelve 12 month Net Profit Variane |
25.43 |
| TTM EPS
Trailing Twelve 12 month EPS |
50.64 |
| TTM PE
Trailing Twelve 12 month PE |
27.52 |
| TTM CPS
Trailing Twelve 12 month CPS |
0 |
| Month CPS
Month Cash Per Share |
0 |
| TTM Depreciation
Trailing Twelve 12 month Depreciation |
57.19 |
| Equity
Latest Equity |
24.55 |
| LTP
Latest Price (BSE/NSE) |
1393 |
| Gross block
Latest Gross Block |
1366.62 |
| Loans
Total loans |
56.77 |
| Advances
Latest Advances for Banks |
0 |
| Net profit asset
Latest Assets |
0 |
| Year OPM
Full Year Operating Profit Margin |
29.8 |
| Year GPM
Full Year Gross Profit Margin |
31.9 |
| Quarter OPM
Latest quater Operation Profit Margin |
33.1 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| + Sales | 507 | 642 | 650 | 602 | 588 | 673 | 689 | 640 |
| YOY Sales Growth % | -15% | 12% | 21% | 2% | 16% | 5% | 6% | 6% |
| Gross Sales | 507 | 642 | 650 | 602 | 588 | 673 | 689 | 640 |
| + Expenses | 373 | 452 | 451 | 430 | 409 | 467 | 475 | 429 |
| Material Cost % | 50% | 45% | 43% | 44% | 56% | 41% | 27% | 39% |
| Raw Material Cost | 239 | 288 | 280 | 269 | 289 | 276 | 229 | 253 |
| Change in Inventory | 14 | 2 | -2 | -1 | 40 | 0 | -42 | -2 |
| Manufacturing Cost % | 17% | 16% | 16% | 16% | 16% | 19% | 18% | 16% |
| Employee Cost % | 12% | 10% | 10% | 10% | 11% | 10% | 11% | 11% |
| Other Cost % | -5% | -1% | 1% | 0% | -14% | 0% | 12% | 1% |
| Raw Materials % | 47% | 45% | 43% | 45% | 49% | 41% | 33% | 40% |
| Stock Adjustments % | -3% | -0% | 0% | 0% | -7% | 0% | 6% | 0% |
| Other Manufacturing Expenses % | 17% | 16% | 16% | 16% | 16% | 19% | 18% | 16% |
| Operating Profit | 134 | 190 | 198 | 172 | 179 | 206 | 215 | 212 |
| OPM % | 27% | 30% | 31% | 29% | 30% | 31% | 31% | 33% |
| + Other Income | 9 | 10 | 10 | 9 | 15 | 14 | 23 | 22 |
| Miscellaneous Income | 9 | 10 | 10 | 9 | 15 | 14 | 23 | 22 |
| Interest | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 15 | 15 | 16 | 17 | 18 | 20 | 20 | 21 |
| Profit before tax | 127 | 185 | 191 | 163 | 174 | 198 | 216 | 212 |
| + Tax % | 25% | 26% | 26% | 25% | 25% | 24% | 25% | 25% |
| Current Tax | 30 | 47 | 48 | 39 | 40 | 54 | 51 | 50 |
| Deferred Tax | 2 | 1 | 2 | 3 | 4 | -6 | 2 | 2 |
| + Net Profit | 95 | 137 | 142 | 122 | 130 | 150 | 163 | 160 |
| Extraordinary Income / Expense | 0 | 0 | 0 | 0 | 0 | -26 | 0 | 0 |
| Exceptional Item | 0 | 0 | 0 | 0 | 0 | -26 | 0 | 0 |
| EPS in Rs |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| + Sales | 0 | 886 | 1,537 | 1,885 | 2,123 | 2,161 | 2,283 | 2,387 | 2,552 |
| Sales Growth % | 354468% | 73% | 23% | 13% | 2% | 6% | 5% | 7% | |
| Gross Sales | 1,885 | 2,123 | 2,161 | 2,283 | 2,387 | 2,552 | |||
| + Expenses | 0 | 1,242 | 1,075 | 1,294 | 1,507 | 1,519 | 1,609 | 1,704 | 1,780 |
| Material Cost % | 36% | 37% | 43% | 47% | 48% | 46% | 42% | 43% | 40% |
| Raw Material Cost | 0 | 634 | 669 | 948 | 978 | 1,069 | 1,025 | 1,010 | 1,024 |
| Change in Inventory | 0 | -302 | -5 | -71 | 41 | -84 | -57 | 27 | 4 |
| Manufacturing Cost % | 0% | 15% | 12% | 10% | 11% | 12% | 12% | 12% | 13% |
| Employee Cost % | 60% | 12% | 9% | 8% | 8% | 8% | 11% | 11% | 11% |
| Other Cost % | -32% | 75% | 5% | 5% | 4% | 5% | 5% | 5% | 6% |
| Raw Materials % | 16% | 71% | 43% | 50% | 46% | 49% | 45% | 42% | 40% |
| Stock Adjustments % | -20% | 34% | 0% | 4% | -2% | 4% | 2% | -1% | -0% |
| Power & Fuel % | 0% | 7% | 5% | 4% | 5% | 5% | 5% | 5% | 4% |
| Other Manufacturing Expenses % | 0% | 9% | 7% | 6% | 6% | 6% | 7% | 7% | 8% |
| Selling & Administration % | 0% | 5% | 3% | 3% | 2% | 3% | 3% | 4% | 3% |
| Miscellaneous Expenses % | 8% | 2% | 2% | 2% | 2% | 2% | 2% | 2% | 3% |
| Operating Profit | 0 | -355 | 463 | 591 | 616 | 642 | 674 | 683 | 772 |
| OPM % | 36% | -40% | 30% | 31% | 29% | 30% | 30% | 29% | 30% |
| + Other Income | 0 | 0 | 12 | 1 | 15 | 29 | 12 | 35 | 60 |
| Miscellaneous Income | 2 | 15 | 29 | 12 | 35 | 60 | |||
| Interest | 0 | 1 | 34 | 88 | 28 | 1 | 2 | 2 | 5 |
| Depreciation | 0 | 19 | 29 | 33 | 38 | 42 | 53 | 61 | 75 |
| Profit before tax | 471 | 565 | 629 | 631 | 654 | 751 | |||
| + Tax % | 25% | 26% | 26% | 25% | 26% | 25% | |||
| Current Tax | 0 | 26 | 99 | 113 | 138 | 151 | 152 | 162 | 184 |
| Deferred Tax | 0 | 7 | 9 | 7 | 9 | 11 | 8 | 6 | 3 |
| + Net Profit | 352 | 419 | 467 | 471 | 486 | 564 | |||
| Profit Growth % | 19% | 12% | 1% | 3% | 16% | ||||
| Extraordinary Income / Expense | 0 | 0 | 0 | 0 | 0 | -26 | |||
| Exceptional Item | 0 | 0 | 0 | 0 | 0 | -26 | |||
| EPS in Rs |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0 | 2 | 2 | 2 | 25 | 25 | 25 | 25 | 25 |
| Reserves | -1 | 86 | 400 | 751 | 2,030 | 2,114 | 2,308 | 2,793 | 3,308 |
| + Borrowings | 0 | 0 | 0 | 0 | 3 | 19 | 17 | 57 | 57 |
| Unsecured Borrowings | 0 | 0 | 0 | 0 | 3 | 19 | 17 | 57 | 57 |
| + Other Liabilities | 1 | 1,387 | 1,324 | 1,244 | 414 | 545 | 501 | 537 | 594 |
| Current Liabilities | 1 | 1,390 | 1,324 | 1,246 | 415 | 539 | 490 | 526 | 570 |
| Provisions | 0 | 16 | 22 | 34 | 26 | 15 | 12 | 17 | 36 |
| Other liability items | 0 | 0 | 0 | 0 | 0 | 8 | 16 | 19 | 36 |
| Total Liabilities | 0 | 1,475 | 1,726 | 1,997 | 2,471 | 2,702 | 2,850 | 3,411 | 3,983 |
| + Fixed Assets | 0 | 456 | 546 | 573 | 595 | 781 | 805 | 955 | 1,038 |
| Gross Block | 0 | 476 | 595 | 652 | 711 | 936 | 1,012 | 1,219 | 1,367 |
| Accumulated Depreciation | 0 | 19 | 49 | 79 | 116 | 156 | 207 | 264 | 329 |
| CWIP | 0 | 80 | 11 | 14 | 92 | 62 | 106 | 102 | 284 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 478 | 780 |
| + Other Assets | 0 | 939 | 1,169 | 1,410 | 1,784 | 1,860 | 1,939 | 1,877 | 1,881 |
| Inventories | 0 | 401 | 413 | 513 | 516 | 604 | 667 | 674 | 692 |
| Trade receivables | 0 | 448 | 639 | 620 | 673 | 807 | 765 | 970 | 1,073 |
| Cash Equivalents | 0 | 2 | 10 | 116 | 512 | 309 | 302 | 71 | 2 |
| Loans n Advances | 0 | 82 | 99 | 153 | 64 | 132 | 187 | 150 | 114 |
| Other asset items | 0 | 6 | 8 | 9 | 19 | 8 | 19 | 12 | 0 |
| Total Assets | 0 | 1,475 | 1,726 | 1,997 | 2,471 | 2,702 | 2,850 | 3,411 | 3,983 |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| + Cash from Operating Activity | 0 | 10 | 195 | 388 | 598 | 306 | 414 | 392 | 565 |
| Profit Before Tax & Extraordinary Items | 0 | 228 | 421 | 471 | 565 | 629 | 631 | 654 | 751 |
| Depreciation | 0 | 19 | 29 | 33 | 38 | 42 | 53 | 61 | 75 |
| Interest (Net) | 0 | 0 | 33 | 87 | 21 | -15 | -10 | -18 | 4 |
| Profit / Loss on Sale of Assets | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 2 | 1 |
| Profit / Loss on Sale of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -9 |
| Provisions & Write-offs (Net) | 0 | 0 | 2 | 4 | 8 | 13 | 31 | 41 | 84 |
| Profit / Loss in Forex | 0 | -1 | -9 | 9 | 0 | 1 | 0 | 2 | -11 |
| Receivables | 0 | -93 | -198 | -41 | 29 | -207 | -17 | -205 | -89 |
| Inventories | 0 | 59 | -12 | -101 | -3 | -97 | -83 | -39 | -67 |
| Trade Payables | 0 | -59 | 19 | 34 | 74 | 91 | -34 | 19 | -13 |
| Direct Taxes Paid | 0 | -24 | -93 | -109 | -138 | -154 | -163 | -163 | -173 |
| + Cash from Investing Activity | 0 | -9 | -51 | -69 | -122 | -147 | -116 | -616 | -570 |
| Purchase of Fixed Assets | 0 | -9 | -51 | -68 | -132 | -163 | -129 | -166 | -307 |
| Sale of Fixed Assets | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 1 | 1 |
| Interest Received | 0 | 0 | 0 | 0 | 7 | 16 | 12 | 20 | 1 |
| Others | 0 | 0 | 0 | -3 | 3 | 0 | 0 | -470 | -265 |
| + Cash from Financing Activity | 0 | 1 | -137 | -214 | -79 | -388 | -279 | -6 | -64 |
| Proceeds from Issue of Shares | 0 | 2 | 0 | 0 | 1,012 | 0 | 0 | 1 | 10 |
| Proceeds from Other Long-Term Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Repayment of Long-Term Borrowings | 0 | -1 | -137 | -214 | -961 | 0 | 0 | 0 | 0 |
| Repayment of Financial Liabilities | 0 | 0 | 0 | 0 | -1 | -1 | -2 | -4 | -8 |
| Dividend Paid | 0 | 0 | 0 | 0 | -129 | -386 | -276 | 0 | -61 |
| Net Cash Flow | 0 | 2 | 8 | 106 | 397 | -228 | 18 | -230 | -69 |